Clinical Scorecard: Increasing Rates of TURP Re-treatment in the 21st Century: Insights from Veterans Health Administration Data
At a Glance
Category
Detail
Condition
Benign prostatic hyperplasia (BPH)
Key Mechanisms
Proliferation of stromal and epithelial cells in prostate transition zone causing urethral narrowing, increased prostatic volume, and stromal muscle tone leading to lower urinary tract symptoms (LUTS)
Target Population
Middle-aged and older men, specifically adult male Veterans
Care Setting
Veterans Affairs healthcare system, surgical and medical management settings
Key Highlights
TURP remains the gold standard surgical treatment for BPH despite decreased usage over time due to medical management and new technologies.
Patients undergoing TURP before 2001 were generally healthier, less obese, and less likely to have preoperative urinary retention or incontinence compared to those treated after 2001.
Increased rates of TURP re-treatment in the 21st century may be associated with less aggressive tissue resection and changes in surgical technique.
Guideline-Based Recommendations
Diagnosis
Use ICD-9 and ICD-10 codes to identify BPH and related urinary conditions.
Assess preoperative urinary retention, urethral stricture, and urinary incontinence using diagnostic codes.
Management
First-line therapy for BPH includes medical management with alpha-blockers, 5-alpha reductase inhibitors, and phosphodiesterase type 5 inhibitors.
TURP is indicated for patients failing medical management or with significant symptoms.
Exclude patients with prior BPH surgeries before TURP to ensure accurate outcome assessment.
Monitoring & Follow-up
Monitor for reoperation rates within 5 years post-TURP.
Assess postoperative urinary incontinence types, urethral stricture, and need for BPH medication refills.
Evaluate 30-day and 90-day postoperative complications including urinary tract infection, blood transfusion, and clot evacuation.
Risks
Potential for increased reoperation rates with less aggressive TURP resections.
Postoperative urinary incontinence and urethral strictures are notable complications.
Higher comorbidity and obesity may influence surgical outcomes.
Patient & Prescribing Data
Adult male Veterans undergoing TURP between 1996 and 2024
Patients treated after 2001 had higher preoperative use of BPH medications (75%) compared to pre-2001 patients (25%), indicating increased medical management prior to surgery.
Clinical Best Practices
Carefully evaluate patient comorbidities, BMI, and preoperative urinary conditions before TURP.
Consider the timing and aggressiveness of TURP resection to optimize durability and reduce re-treatment rates.
Counsel patients on the likelihood of postoperative complications and potential need for reoperation based on era and surgical technique.
Utilize comprehensive electronic health record data to monitor outcomes and guide clinical decision-making.
